Related references
Note: Only part of the references are listed.Neutrophil extracellular traps: A novel target for the treatment of stroke
Ziyuan Zhao et al.
PHARMACOLOGY & THERAPEUTICS (2023)
Projected Global Trends in Ischemic Stroke Incidence, Deaths and Disability-Adjusted Life Years From 2020 to 2030
Liyuan Pu et al.
STROKE (2023)
Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke
Tao Peng et al.
BIOMOLECULES (2023)
World Stroke Organization (WSO): Global Stroke Fact Sheet 2022
Valery L. Feigin et al.
INTERNATIONAL JOURNAL OF STROKE (2022)
Advances in Acute Ischemic Stroke Therapy
Yunyun Xiong et al.
CIRCULATION RESEARCH (2022)
The End of Tissue-Type Plasminogen Activator's Reign?
Imad Derraz
STROKE (2022)
Platelet-Neutrophil Association in NETs-Rich Areas in the Retrieved AIS Patient Thrombi
Ghulam Jeelani Pir et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke
Kaibin Shi et al.
CIRCULATION RESEARCH (2021)
Cerebral endothelial cell-derived small extracellular vesicles enhance neurovascular function and neurological recovery in rat acute ischemic stroke models of mechanical thrombectomy and embolic stroke treatment with tPA
Chao Li et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke
Shumei Man et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
2B, 2C, or 3 What Should Be the Angiographic Target for Endovascular Treatment in Ischemic Stroke?
Natalie E. LeCouffe et al.
STROKE (2020)
Sex differences in risk factors, treatment, and prognosis in acute stroke
Solveig Dahl et al.
WOMENS HEALTH (2020)
Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke
Chunyang Wang et al.
STROKE (2019)
Platelet Function in Aging
Jessica Le Blanc et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Treatment of Traumatic Brain Injury with Vepoloxamer (Purified Poloxamer 188)
Yanlu Zhang et al.
JOURNAL OF NEUROTRAUMA (2018)
Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury
Ye Xiong et al.
NEURAL REGENERATION RESEARCH (2018)
Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke
Celina Ducroux et al.
STROKE (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Challenges and Opportunities of Endovascular Stroke Therapy
Mayank Goyal et al.
ANNALS OF NEUROLOGY (2016)
Diabetes Mellitus Impairs Cognitive Function in Middle-Aged Rats and Neurological Recovery in Middle-Aged Rats After Stroke
Li Zhang et al.
STROKE (2016)
Alteplase versus tenecteplase for thrombolysis after Cross Mark ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study
Xuya Huang et al.
LANCET NEUROLOGY (2015)
Focal embolic cerebral ischemia in the rat
Li Zhang et al.
NATURE PROTOCOLS (2015)
Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment
Mina Elahy et al.
IMMUNITY & AGEING (2015)
Microvascular Thrombosis, Fibrinolysis, Ischemic Injury, and Death After Cerebral Thromboembolism Are Affected by Levels of Circulating α2-Antiplasmin
Guy L. Reed et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Combination Treatment With N-Acetyl-Seryl-Aspartyl-Lysyl-Proline and Tissue Plasminogen Activator Provides Potent Neuroprotection in Rats After Stroke
Li Zhang et al.
STROKE (2014)
Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
Jeffrey L. Saver et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Blood-brain barrier permeability derangements in posterior circulation ischemic stroke: Frequency and relation to hemorrhagic transformation
Meng Lee et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes
Gregg C. Fonarow et al.
CIRCULATION (2011)
Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States A Doubling of Treatment Rates Over the Course of 5 Years
Opeolu Adeoye et al.
STROKE (2011)
Erythropoietin Amplifies Stroke-Induced Oligodendrogenesis in the Rat
Li Zhang et al.
PLOS ONE (2010)
Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke Real-World Experience and a Call for Action
Rohit Bhatia et al.
STROKE (2010)
Combination Treatment With VELCADE and Low-Dose Tissue Plasminogen Activator Provides Potent Neuroprotection in Aged Rats After Embolic Focal Ischemia
Li Zhang et al.
STROKE (2010)
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
Werner Hacke et al.
LANCET NEUROLOGY (2009)
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes
Mathew J. Reeves et al.
LANCET NEUROLOGY (2008)
Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats
Vincent A. DiNapoli et al.
NEUROBIOLOGY OF AGING (2008)
National US estimates of recombinant tissue plasminogen activator use - ICD-9 codes substantially underestimate
Dawn Kleindorfer et al.
STROKE (2008)
Tumor necrosis factor-α is involved in thrombolytic-induced hemorrhage following embolic strokes in rabbits
Paul A. Lapchak
BRAIN RESEARCH (2007)
Heart disease and stroke statistics - 2007 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2007)
Accelerated infarct development, cytogenesis and apoptosis following transient cerebral ischemia in aged rats
Aurel Popa-Wagner et al.
ACTA NEUROPATHOLOGICA (2007)
Sex-based differences in the effect of intra-arterial treatment of stroke - Analysis of the PROACT-2 study
Michael D. Hill et al.
STROKE (2006)
Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly
K Yamamoto et al.
CARDIOVASCULAR RESEARCH (2005)
Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke - A pooled analysis of randomized clinical trials
DM Kent et al.
STROKE (2005)
Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke
L Zhang et al.
STROKE (2003)
A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia
L Zhang et al.
JOURNAL OF NEUROSCIENCE METHODS (2002)
Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion
ZG Zhang et al.
BRAIN RESEARCH (2001)
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats
JL Chen et al.
STROKE (2001)
Brain injury and cerebrovascular fibrin deposition correlate with reduced antithrombotic brain capillary functions in a hypertensive stroke model
T Ninomia et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Share Paper
